跳至主要内容
临床试验/NCT05141838
NCT05141838Unknown4 期

Vitamin D Status and Bone Metabolism Status in Children With Congenital Epidermolysis Bullosa

National Medical Research Center for Children's Health, Russian Federation1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2020年11月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
110
试验地点
1
主要终点
Phosphorus-calcium metabolism assessment

研究概览

简要总结

This retrospective prospective study is aimed at studying the level of vitamin D supply and identifying markers of bone tissue remodeling in order to develop approaches to the prevention of osteopenia and osteoporosis in children with congenital epidermolysis bullosa.

详细描述

This retrospective prospective interventional study will examine vitamin D availability and its relationship with clinical disease, patient gender and age, and season. The mechanisms of impairment of phosphorus-calcium metabolism and bone tissue metabolism will be analyzed on the basis of biochemical parameters and instrumental research methods in children with dystrophic epidermolysis bullosa in order to develop personalized approaches for correcting vitamin D status and bone metabolism disorders in children with epidermolysis bullosa, followed by an assessment of their clinical efficacy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
0 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Verified diagnosis of epidermolysis bullosa;
  • Signing by parents (legal representatives) of informed consent to participate in the study and fulfill the requirements of the study

排除标准

  • not planned

研究组 & 干预措施

Group 1 - Vitamin D

Experimental

Patients receiving vitamin D supplements in therapy

干预措施: Vitamin D (Drug)

Group 2 - Oral nutritional supplement

Experimental

Patients receiving oral nutritional supplement

干预措施: Oral nutritional supplement (Dietary Supplement)

Group 3 - Vitamin D+Oral nutritional supplement

Experimental

Patients receiving vitamin D supplements and oral nutritional supplement in therapy

干预措施: Vitamin D (Drug)

Group 3 - Vitamin D+Oral nutritional supplement

Experimental

Patients receiving vitamin D supplements and oral nutritional supplement in therapy

干预措施: Oral nutritional supplement (Dietary Supplement)

结局指标

主要结局

Phosphorus-calcium metabolism assessment

时间窗: 24 week

Study of levels of calcium, phosphorus, parathyroid hormone, creatinine, magnesium, albumin in the blood

Vitamin D level

时间窗: 24 week

Study of the provision of vitamin D in children with dystrophic and simple forms of epidermolysis bullosa based on the level of 25 (OH) vitamin D (25 hydroxycholecalciferol) in the blood

Assessment of the state of bone tissue

时间窗: 24 week

Study of levels of alkaline phosphatase, osteocalcin, b-CrossLaps, P1NP in the blood

Assessment of indicators of physical development

时间窗: 24 wee

Z-score calculation (weight-for-height z-score)

次要结局

  • Assessment of bone mineral density(24 week)
  • Bone age assessment(24 week)

研究者

发起方
National Medical Research Center for Children's Health, Russian Federation
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验